Haleon to sell overseas nicotine therapy business to Dr. Reddy’s

seekingalpha06-26

Consumer healthcare company Haleon (NYSE:HLN) announced an agreement on Wednesday to sell its nicotine replacement therapy (NRT) business outside the U.S. to a subsidiary of the Indian drugmaker Dr. ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2446185393?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1455070559/image_1455070559.jpg","is_english":true,"pubTime":"2024-06-26 20:30","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2446185393","market":"sg","top_or_hot":-1,"title":"Haleon to sell overseas nicotine therapy business to Dr. Reddy’s","media":"seekingalpha","content":"<div>\n<p>Consumer healthcare company Haleon (NYSE:HLN) announced an agreement on Wednesday to sell its nicotine replacement therapy (NRT) business outside the U.S. to a subsidiary of the Indian drugmaker Dr. ...</p>\n\n<a href=\"https://seekingalpha.com/news/4119453-haleon-sell-overseas-nicotine-therapy-business\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Haleon to sell overseas nicotine therapy business to Dr. Reddy’s</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHaleon to sell overseas nicotine therapy business to Dr. Reddy’s\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-26 20:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4119453-haleon-sell-overseas-nicotine-therapy-business><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Consumer healthcare company Haleon (NYSE:HLN) announced an agreement on Wednesday to sell its nicotine replacement therapy (NRT) business outside the U.S. to a subsidiary of the Indian drugmaker Dr. ...</p>\n\n<a href=\"https://seekingalpha.com/news/4119453-haleon-sell-overseas-nicotine-therapy-business\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4557","symbol_name":"大麻股","start_time":0,"source_url":"https://seekingalpha.com/news/4119453-haleon-sell-overseas-nicotine-therapy-business","article_id":"2446185393","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1455070559/image_1455070559.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2446185393","pubTimestamp":1719405019,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Consumer healthcare company Haleon  announced an agreement on Wednesday to sell its nicotine replacement therapy  business outside the U.S. to a subsidiary of the Indian drugmaker Dr. Reddy's Laboratories . Per the terms, Dr. Reddy's Laboratories SA, a unit of Dr. Reddy's , will buy Haleon's  overseas NRT portfolio in a transaction expected to be completed in early Q4 2024. In return, the company will receive 500M  from Dr. Reddy's , with payments structured as 458 in upfront cash and up to 42M in performance-based payments payable during 2025 and H1 2026. Payments for inventory sales will also be received over the period. The consumer care spinoff of GSK  said it would use net proceeds based on capital allocation requirements, including those aimed at reducing debt. Haleon's  NRT products, available in gum, lozenge, and patch forms across more than 30 markets, generated 217M in net revenue for the company in 2023. Assuming the transaction goes ahead in Q4, the company expects its FY 2","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4557":"大麻股","HLN":"Haleon","BK4523":"印度概念","RDY":"如瑞迪博士","BK4585":"ETF&股票定投概念","LU1829250122.USD":"高盛欧洲核心股票组合Acc","GSK.UK":"葛兰素史克","NRT":"北欧皇家石油信托","BK4213":"石油与天然气的勘探与生产","BK4588":"碎股","BK4532":"文艺复兴科技持仓","BK4007":"制药","GSK":"葛兰素史克","BK4183":"个人用品"},"translate_title":"Haleon将海外尼古丁治疗业务出售给Dr.Reddy's","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GSK":1,"HLN":1,"NRT":1,"RDY":1,"GSK.UK":0.6},"content_text":"Consumer healthcare company Haleon (NYSE:HLN) announced an agreement on Wednesday to sell its nicotine replacement therapy (NRT) business outside the U.S. to a subsidiary of the Indian drugmaker Dr. Reddy's Laboratories (NYSE:RDY). Per the terms, Dr. Reddy's Laboratories SA, a unit of Dr. Reddy's (RDY), will buy Haleon's (HLN) overseas NRT portfolio in a transaction expected to be completed in early Q4 2024. In return, the company will receive £500M ($633M) from Dr. Reddy's (RDY), with payments structured as £458 in upfront cash and up to £42M in performance-based payments payable during 2025 and H1 2026. Payments for inventory sales will also be received over the period. The consumer care spinoff of GSK (GSK) said it would use net proceeds based on capital allocation requirements, including those aimed at reducing debt. Haleon's (HLN) NRT products, available in gum, lozenge, and patch forms across more than 30 markets, generated £217M in net revenue for the company in 2023. Assuming the transaction goes ahead in Q4, the company expects its FY 2024 net revenue and adjusted operating profit to dilute by ~0.5% and ~1%, respectively.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2446185393"}